(0.09%) 5 522.00 points
(0.13%) 39 896 points
(0.19%) 19 788 points
(-0.04%) $81.60
(0.68%) $2.83
(-0.22%) $2 339.20
(0.10%) $29.56
(0.47%) $1 006.50
(0.05%) $0.932
(-0.11%) $10.52
(0.01%) $0.788
(-0.84%) $87.26
0.05% $ 0.205
Live Chart Being Loaded With Signals
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck...
Stats | |
---|---|
Dzisiejszy wolumen | 2.56M |
Średni wolumen | 85 425 |
Kapitalizacja rynkowa | 1.05M |
EPS | $-1.230 ( Q1 | 2024-05-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0726 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0450 (21.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-01 | Luther Sanjeev | Buy | 1 685 218 | Stock Option (right to buy) |
2024-01-01 | Clarke Dorothy J | Buy | 168 521 | Stock Option (right to buy) |
2024-01-01 | Luther Sanjeev | Buy | 0 | |
2023-12-14 | Cherington Charles | Buy | 3 125 976 | Warrants (right to buy) |
2023-12-14 | Cherington Charles | Buy | 2 307 692 | Warrants (right to buy) |
INSIDER POWER |
---|
64.65 |
Last 79 transactions |
Buy: 23 565 099 | Sell: 3 570 325 |
Wolumen Korelacja
Eterna Therapeutics Inc. Korelacja
10 Najbardziej negatywne korelacje | |
---|---|
GLEE | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eterna Therapeutics Inc. Korelacja - Waluta/Towar
Eterna Therapeutics Inc. Finanse
Annual | 2023 |
Przychody: | $68 000.00 |
Zysk brutto: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2023 |
Przychody: | $68 000.00 |
Zysk brutto: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-497 000 (0.00 %) |
EPS: | $-8.06 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-56.40 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eterna Therapeutics Inc.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej